vs
bioAffinity Technologies, Inc.(BIAF)与iSpecimen Inc.(ISPC)财务数据对比。点击上方公司名可切换其他公司
bioAffinity Technologies, Inc.的季度营收约是iSpecimen Inc.的30.8倍($1.6M vs $51.8K)。bioAffinity Technologies, Inc.净利率更高(-197.0% vs -9662.2%,领先9465.2%)。bioAffinity Technologies, Inc.同比增速更快(-27.8% vs -96.5%)。过去两年bioAffinity Technologies, Inc.的营收复合增速更高(-18.6% vs -85.0%)
bioAffinity Technologies是一家处于临床阶段的生物技术企业,专注于研发可用于癌症、呼吸系统疾病早期检测的非侵入性体外诊断产品,面向全球医疗市场,致力于提供高准确率的便捷诊断方案,改善患者诊疗体验与预后效果。
Specimen Products是一家总部位于芝加哥的乐器与音响设备制造商,由制琴师伊恩·施纳勒创立,主打定制吉他、电子管功放与号角音箱产品。品牌还依托旗下芝加哥吉他制作学院开设吉他、电子管功放的设计、制作与维修课程,工坊也面向公众提供设备维修服务,可调用稀有 vintage 厂商的零件储备开展维修。
BIAF vs ISPC — 直观对比
营收规模更大
BIAF
是对方的30.8倍
$51.8K
营收增速更快
BIAF
高出68.6%
-96.5%
净利率更高
BIAF
高出9465.2%
-9662.2%
两年增速更快
BIAF
近两年复合增速
-85.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $1.6M | $51.8K |
| 净利润 | $-3.1M | $-5.0M |
| 毛利率 | — | -964.4% |
| 营业利润率 | -196.9% | -5192.9% |
| 净利率 | -197.0% | -9662.2% |
| 营收同比 | -27.8% | -96.5% |
| 净利润同比 | -5.7% | 17.3% |
| 每股收益(稀释后) | $-3.59 | $-0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BIAF
ISPC
| Q4 25 | $1.6M | $51.8K | ||
| Q3 25 | $1.4M | $106.6K | ||
| Q2 25 | $1.3M | $713.1K | ||
| Q1 25 | $1.9M | $1.1M | ||
| Q4 24 | $2.2M | $1.5M | ||
| Q3 24 | $2.4M | $2.7M | ||
| Q2 24 | $2.4M | $2.9M | ||
| Q1 24 | $2.4M | $2.3M |
净利润
BIAF
ISPC
| Q4 25 | $-3.1M | $-5.0M | ||
| Q3 25 | $-5.1M | $-2.8M | ||
| Q2 25 | $-4.1M | $-1.0M | ||
| Q1 25 | $-2.7M | $-1.7M | ||
| Q4 24 | $-3.0M | $-6.0M | ||
| Q3 24 | $-2.0M | $-1.4M | ||
| Q2 24 | $-2.1M | $-2.1M | ||
| Q1 24 | $-2.0M | $-2.9M |
毛利率
BIAF
ISPC
| Q4 25 | — | -964.4% | ||
| Q3 25 | — | -47.0% | ||
| Q2 25 | — | 44.4% | ||
| Q1 25 | — | 42.4% | ||
| Q4 24 | — | 13.5% | ||
| Q3 24 | — | 43.4% | ||
| Q2 24 | — | 51.9% | ||
| Q1 24 | — | 58.4% |
营业利润率
BIAF
ISPC
| Q4 25 | -196.9% | -5192.9% | ||
| Q3 25 | -158.6% | -2655.2% | ||
| Q2 25 | -198.2% | -255.4% | ||
| Q1 25 | -141.7% | -154.9% | ||
| Q4 24 | -133.5% | -395.8% | ||
| Q3 24 | -84.0% | -64.1% | ||
| Q2 24 | -87.1% | -76.2% | ||
| Q1 24 | -80.8% | -131.0% |
净利率
BIAF
ISPC
| Q4 25 | -197.0% | -9662.2% | ||
| Q3 25 | -349.3% | -2608.7% | ||
| Q2 25 | -319.9% | -146.9% | ||
| Q1 25 | -143.5% | -156.8% | ||
| Q4 24 | -134.4% | -409.8% | ||
| Q3 24 | -85.1% | -54.1% | ||
| Q2 24 | -88.0% | -73.6% | ||
| Q1 24 | -81.5% | -126.7% |
每股收益(稀释后)
BIAF
ISPC
| Q4 25 | $-3.59 | $-0.67 | ||
| Q3 25 | $-4.74 | $-0.48 | ||
| Q2 25 | $-0.17 | $-0.42 | ||
| Q1 25 | $-0.16 | $-0.71 | ||
| Q4 24 | $-17.27 | $-5.40 | ||
| Q3 24 | $-4.84 | $-2.10 | ||
| Q2 24 | $-0.19 | $-3.72 | ||
| Q1 24 | $-0.20 | $-6.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | $6.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.3M | $3.1M |
| 总资产 | $11.0M | $9.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
BIAF
ISPC
| Q4 25 | $6.4M | $6.9M | ||
| Q3 25 | $7.7M | — | ||
| Q2 25 | $802.8K | — | ||
| Q1 25 | $444.7K | — | ||
| Q4 24 | $1.1M | $1.9M | ||
| Q3 24 | $756.6K | $1.8M | ||
| Q2 24 | $801.3K | $2.2M | ||
| Q1 24 | $2.5M | $2.1M |
股东权益
BIAF
ISPC
| Q4 25 | $7.3M | $3.1M | ||
| Q3 25 | $8.9M | $3.1M | ||
| Q2 25 | $-2.1M | $622.0K | ||
| Q1 25 | $1.4M | $1.7M | ||
| Q4 24 | $2.6M | $3.3M | ||
| Q3 24 | $3.1M | $4.7M | ||
| Q2 24 | $3.4M | $6.1M | ||
| Q1 24 | $5.3M | $6.8M |
总资产
BIAF
ISPC
| Q4 25 | $11.0M | $9.5M | ||
| Q3 25 | $11.5M | $9.0M | ||
| Q2 25 | $4.8M | $6.0M | ||
| Q1 25 | $5.5M | $6.8M | ||
| Q4 24 | $6.5M | $9.4M | ||
| Q3 24 | $6.6M | $11.3M | ||
| Q2 24 | $6.7M | $11.9M | ||
| Q1 24 | $8.0M | $12.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.6M | $-916.9K |
| 自由现金流经营现金流 - 资本支出 | $-2.6M | — |
| 自由现金流率自由现金流/营收 | -160.7% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.4M | — |
8季度趋势,按日历期对齐
经营现金流
BIAF
ISPC
| Q4 25 | $-2.6M | $-916.9K | ||
| Q3 25 | $-2.5M | $-2.0M | ||
| Q2 25 | $-2.6M | $-192.2K | ||
| Q1 25 | $-1.6M | $-1.1M | ||
| Q4 24 | $-1.7M | $-3.6M | ||
| Q3 24 | $-1.7M | $-1.1M | ||
| Q2 24 | $-1.5M | $-1.5M | ||
| Q1 24 | $-2.3M | $-2.1M |
自由现金流
BIAF
ISPC
| Q4 25 | $-2.6M | — | ||
| Q3 25 | $-2.5M | — | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-1.7M | $-3.6M | ||
| Q3 24 | $-1.7M | $-1.1M | ||
| Q2 24 | $-1.6M | — | ||
| Q1 24 | $-2.4M | $-2.1M |
自由现金流率
BIAF
ISPC
| Q4 25 | -160.7% | — | ||
| Q3 25 | -171.8% | — | ||
| Q2 25 | -209.6% | — | ||
| Q1 25 | -91.3% | — | ||
| Q4 24 | -76.0% | -242.7% | ||
| Q3 24 | -73.1% | -41.1% | ||
| Q2 24 | -65.1% | — | ||
| Q1 24 | -99.2% | -90.9% |
资本支出强度
BIAF
ISPC
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.4% | 0.5% | ||
| Q2 24 | 1.2% | 0.0% | ||
| Q1 24 | 1.7% | 0.4% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图